Search - tctmd.com

Displaying 121 - 140 of 215

Sort: Relevancy | Date

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Zening Jin

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) from: EXCEL and NOBLE

Presenter: Yves R. Louvard, John D. Puskas, Davide Capodanno

November 01, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Presenter: Robert A. Guyton, Martin B. Leon, Marc Ruel

October 31, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Presenter: Robert A. Guyton, Martin B. Leon, David E. Kandzari

October 31, 2016

Presentation TCT 2016

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Niels R. Holm

October 31, 2016

Presentation TCT 2016

SYNTAX Stratified NOBLE Results

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Ian Menown

October 31, 2016

Presentation TCT 2016

NOBLE Left main Bifurcation Stent Techniques

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Mitchell Lindsay

October 31, 2016

Presentation TCT 2016

Diabetes in the NOBLE Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Olli A. Kajander

October 31, 2016

Presentation TCT 2016

NOBLE Top Line Results Revisited

Presenter: Evald H. Christiansen, Per Hostrup Nielsen

October 31, 2016

Presentation TCT 2016

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Rationale and Principal Results of the Excel Trial

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Joseph F. Sabik

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Men and Women

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Diabetic and Non-diabetic Patients

Presenter: A. Pieter Kappetein, Marie-Claude Morice

October 31, 2016

Presentation TCT 2016

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Philippe Généreux

October 31, 2016

Advertisement

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

Case Introduction: How Should I Treat?

Highlights (and my Interpretations) from: EXCEL and NOBLE

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

SYNTAX Stratified NOBLE Results

NOBLE Left main Bifurcation Stent Techniques

Diabetes in the NOBLE Trial

NOBLE Top Line Results Revisited

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory

Rationale and Principal Results of the Excel Trial

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

EXCEL Outcomes in Men and Women

EXCEL Outcomes in Diabetic and Non-diabetic Patients

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content